1 - Hemostasis and Coagulation Flashcards
Timing of Hemostasis:
Vasoconstriction (immediately)
Platelet adhesion
Platelet aggregation
Primary Hemostasis
Timing of Hemostasis:
Activation of clotting factors
Fibrin formation
Secondary hemostasis
Timing of Hemostasis:
Activation of fibrinolytic factors
Clot lysis
Fibrinolysis
Key players of Primary Hemostasis
Platelet
Blood vessels
Endpoint of primary hemostasis
Platelet plug
Key players of secondary hemostasis
Coagulation system
Enzymes
Cofactors
Platelets
End product of Secondary hemostasis
Stabilized fibrin clot
Key players of fibrinolysis
Fibrinolytic system
End product of fibrinolysis
Dissolution of fibrin clot (Healing)
Anticoagulant properties of Intact Vascular Intime
- Prostacyclin
- Nitric oxide
- Tissue Factor Pathway Inhibitor
- Thrombomodulin
- Heparan sulfate
providing a smooth inner surface of the blood vessel that prevents harmful turbulence that otherwise may activate platelets and coagulation enzymes
Rhomboid and contiguous ECs
separating procoagulant proteins and platelets in blood from collagen & tissue factor in fibroblasts and smooth muscle cells
ECs as a physical barrier
Platelet inhibitor and a vasodilator
Prostacyclin
induces smooth muscle relaxation and subsequent vasodilation, inhibits platelet activation, and promotes angiogenesis
Nitric oxide
Eicosanoid platelet inhibitor
Prostacyclin
vascular “relaxing” factor
nitric oxide
coagulation extrinsic pathway regulator
tissue factor pathway inhibitor
a protein C coagulation control system activator
thrombomodulin
Procoagulant properties of Damage Vascular Intima:
- Vasoconstriction
- Collagen
- von Willebrand factor
- ADAMTS-13
- P-selectin
- Intercellular adhesion molecules (ICAMs)
- Platelet endothelial cell adhesion molecules (PECAMs)
- Smooth muscle cells and fibroblasts
- Tissue factor
necessary for platelet adhesion to collagen
von Willebrand factor
promotes platelet leukocyte binding
P-selectin
ICAMs (Intercellular adhesion molecules)
PECAMs (Platelet endothelial cell adhesion molecules)
3 fibrinolytic properties:
- Tissue plasminogen activator (TPA)
- Plasminogen activator inhibitor-1 (PAI-1)
- Thrombin-activatable Fibrinolysis Inhibitor (TAFI)
A serine protease, activates fibrinolysis by converting plasminogen to plasmin
Tissue plasminogen activator (TPA)
TPA control protein that inhibits plasmin generation and fibrinolysis
Plasminogen activator inhibitor-1 (PAI-1)
Thrombin-thrombomodulin complex
Thrombin-activatable Fibrinolysis Inhibitor (TAFI)
Activated by thrombin bound to EC membrane thrombomodulin
Thrombin-activatable Fibrinolysis Inhibitor (TAFI)
Platelets are produced from the cytoplasm of bone marrow
megakaryocytes
Platelets function:
Plts roll and cling to non-plt surfaces, reversible
Adhesion
Give clinical significance for Adhesion
Bernard-Soulier Syndrome
von Willebrand disease
Platelets function:
Plts adhere to each other; irreversible
Aggregation
Give clinical significance for Aggregation
Glanzmann thrombasthenia
Afibrinogenemia
Platelets function:
Plts discharge the contents of their granules; irreversible
Secretion
Platelet granule:
B-Thromboglobulin
a-granules
Platelet granule:
Adenosine diphosphate
dense granules
Platelet granule:
Factor V
a-granules
Platelet granule:
Adenosine triphosphate
dense granules
Platelet granule:
protein s
a-granules
Platelet granule:
calcium
dense granules